Core Laboratories CLB Income Statement (2022-2026)

NYSE CLB
$8.99 +0.16 (+1.81%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Core Laboratories Quarterly Income Statement

Periods 18 quarters
Latest Sep 2026

Core Laboratories reported revenue of $132.08M and net income of $5.46M for the quarter ended Sep 2026, down 1.8% year over year. This income statement covers 18 quarters of results from Jun 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue 120.90M125.97M127.57M128.36M127.88M125.34M128.21M129.64M130.58M134.40M129.24M123.59M130.16M134.52M138.26M121.80M124.61M132.08M
Cost of RevenueCost of Rev 97.96M98.93M99.82M101.53M100.30M96.62M101.52M104.59M102.93M106.81M106.20M99.47M103.70M104.90M109.52M102.07M101.37M105.09M
Gross Profit 22.94M27.04M27.76M26.83M27.59M28.73M26.69M25.05M27.65M27.59M23.04M24.12M26.46M29.62M28.74M19.72M23.24M26.99M
Operating items
Amortization - Intangibles 0.17M0.17M0.17M0.11M0.13M0.13M0.13M0.13M0.13M0.13M0.12M0.12M0.11M0.07M0.06M0.21M0.14M0.11M
Depreciation & Amortization - TotalDep. & Amort. (Tot) 4.36M4.17M4.07M4.04M3.94M3.93M3.87M3.84M3.77M3.68M3.66M3.72M3.67M3.59M3.67M3.76M3.83M3.72M
Selling, General & AdministrativeSG&A 11.79M10.26M8.64M9.08M13.65M10.46M10.69M10.63M14.72M10.95M11.27M
Other Operating ExpensesOther Opex -0.08M1.78M0.66M0.03M1.07M-0.67M0.43M-0.85M2.39M4.53M3.88M-2.34M2.97M5.59M1.39M0.65M0.69M0.07M
Operating ExpensesOpex 4.36M4.17M4.07M4.04M3.94M3.93M3.87M15.63M14.03M12.32M12.74M17.36M14.13M14.28M14.30M18.48M14.78M14.99M
Operating IncomeOp. Inc 11.65M14.65M15.62M6.48M18.91M14.67M14.58M8.57M16.01M19.80M14.17M4.42M15.29M20.93M15.83M1.89M9.15M12.07M
Non-operating items
Non Operating Interest Expenses 2.71M3.14M3.08M3.43M3.24M3.15M3.62M3.42M3.21M3.11M2.63M2.60M2.71M2.65M2.61M2.89M2.85M2.79M
Net income details
EBIT 11.65M14.65M15.62M6.48M18.91M14.67M14.58M8.57M16.01M19.80M14.17M4.42M15.29M20.93M15.83M1.89M9.15M12.07M
EBT 8.95M11.51M12.54M3.10M15.67M11.53M10.96M5.15M12.80M16.70M11.55M1.82M12.58M18.28M13.22M-1.00M6.31M9.28M
Tax ProvisionsTaxes 1.80M3.90M5.85M0.61M-7.30M2.31M8.53M1.70M3.61M4.70M4.03M1.75M1.91M3.80M8.09M-0.30M0.51M3.82M
Income After Tax 7.15M7.61M6.69M2.49M22.97M9.22M2.43M3.45M9.19M12.00M7.51M0.07M10.67M14.48M5.13M-0.70M5.80M5.46M
Income from Continuing OperationsIncome (Continuing) 7.15M7.61M6.69M2.49M22.97M9.22M2.43M3.45M9.19M12.00M7.51M0.07M10.67M14.48M5.13M-0.70M5.80M5.46M
Consolidated Net IncomeConsol Net Inc. 7.16M7.65M6.69M2.44M22.93M9.22M2.43M3.49M9.19M12.00M7.47M0.07M10.67M14.52M5.13M-0.75M5.80M5.46M
Net Income Attributable to Noncontrolling InterestsNCI Net Income 0.09M0.13M-0.06M0.07M0.08M-0.04M0.24M0.27M0.16M0.26M0.07M0.22M0.03M0.29M0.18M0.04M-0.16M0.02M
Income towards Parent CompanyParent Net Inc 7.07M7.52M6.75M2.37M22.85M9.26M2.20M3.22M9.03M11.75M7.40M-0.15M10.64M14.24M4.95M-0.79M5.96M5.44M
Net Income towards Common StockholdersNet Income 7.07M7.52M6.75M2.37M22.85M9.26M2.20M3.22M9.03M11.75M7.40M-0.15M10.64M14.24M4.95M-0.79M5.96M5.44M
Additional items
EPS (Basic) 0.150.160.150.050.490.200.050.070.190.250.160.000.230.310.11-0.020.130.12
EPS (Diluted) 0.150.160.140.050.480.190.050.070.190.250.160.000.220.300.11-0.020.130.12
Shares Outstanding 46.32M46.34M46.33M46.63M46.68M46.69M46.68M46.86M46.91M46.92M46.90M46.77M46.63M46.26M46.43M46.07M46.03M45.87M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 47.14M47.01M46.81M47.48M47.50M47.60M47.52M47.70M47.74M47.82M47.69M46.77M47.36M47.08M47.03M46.07M46.88M46.71M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 46.45M46.45M46.63M46.70M46.68M46.70M46.86M46.86M46.91M46.93M46.83M46.70M46.54M46.09M46.10M46.05M45.88M45.82M
EBITDA 16.01M18.82M19.69M10.53M22.84M18.60M18.46M12.41M19.78M23.48M17.84M8.13M18.96M24.52M19.50M5.65M12.98M15.79M
Interest ExpensesInt Expense 2.71M3.14M3.08M3.43M3.24M3.15M3.62M3.42M3.21M3.11M2.63M2.60M2.71M2.65M2.61M2.89M2.85M2.79M
Tax Rate 20.12%33.89%46.64%19.68%20.00%77.80%33.02%28.20%28.15%34.94%96.20%15.19%20.79%61.21%8.04%41.13%

Core Laboratories Income Statement API

Pull Core Laboratories's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CLB&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY